Good Growth Opportunities in Global Branded Generics Market Till 2026
Verfasser: yogesh on Friday, 16 December 2016Branded generics are the drugs which are biosimilars to the innovator products and marketed under different brand names. In other words, branded generics, sometimes also called as ‘value-added generics’ can either be a novel dosage form of an original patented drug or a generic drug with a definite trade name. Branded generics have taken an extensive industry move in recent years to generate the copy of innovator drugs. The branded generics provide a dynamic way to many innovator companies to keep their net profit high as many of them own the subsidiaries which are involved in the production of branded generics. Branded generics differ from ‘commodity generics’ which are pharmaceutical products, generally used as an alternative to innovator product after the expiry of the patent.
Branded Generics Market: Drivers and Restraints
The global branded generics market is expected to grow significantly as large number of pharmaceutical products are going to be off patent within the forecast period. Simple marketing approval procedures, opportunity to reduce government spending on healthcare, entry of new players, changing prescription practices, greater profit margin are some other factors which are anticipated to boost the global branded generics market. Whereas, huge competition from branded drugs and commodity generic products will pose the major challenge for the global branded generics market.